Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ELV Relative to the S&P 500

ELV Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Elevance Health, Inc. (NYSE:ELV) seasonal charts above shows that a Buy Date of August 28 and a Sell Date of January 19 has resulted in a geometric average return of 6.8% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 6.37% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance’s reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

To download ELV seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ELV